Chimeric poly peptides and the therapeutic use thereof against a Flaviviridae infection
US8337857B2 · kind B2 · utility
10Cited by
0References
21Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 20, 2006 |
| Grant date | Dec 25, 2012 |
| Priority date | — |
| Expiry date | Jun 21, 2028 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to building a chimeric polypeptide used for preventing or treating a Flaviviridae infection. The use of the inventive chimeric polypeptide for producing recombinant viral vectors such as a measles living viral vector is also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.